Sold at 5.86p.
I missed to chance to sell at the peak, although of course that is benefitting from hindsight. It seems the Covid vaccines will arrive much faster than the Nuvec platform can be developed, so I can foresee the share price falling further in the short term. I may open a position again in the future when Nuvec is further along in development.
14 September 2020